Pegfilgrastim-cbqv recalls
The FDA has published 1 recall involving Pegfilgrastim-cbqv since 2026. The latest was reported on 18 Feb 2026. Most were for temperature abuse. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2026
Last 12 months1reported
Class I1100% of total
Ongoing1latest 18 Feb 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 100%Class II 0 0%Class III 0 0%
Why pegfilgrastim-cbqv is recalled
Companies
By year
Ongoing pegfilgrastim-cbqv recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Udenyca, pegfilgrastim-cbqv injection recalled by McKessonUdenyca | McKesson | Temperature Abuse | Nationwide |
All pegfilgrastim-cbqv recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Udenyca, pegfilgrastim-cbqv injection recalled by McKessonUdenyca | McKesson | Temperature Abuse | Nationwide |
Should you stop taking Pegfilgrastim-cbqv?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.